Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
63.84 EUR | +0.09% |
|
-.--% | -.--% |
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 8.61B | - | ||
-3.63% | 1.37B | D | ||
-20.03% | 1.24B | B+ | ||
-34.24% | 689M | - | - | |
-.--% | 616M | - | - | |
+9.67% | 475M | - | ||
+1.81% | 433M | - | - | |
-37.52% | 274M | - | - | |
-67.35% | 239M | - | ||
+1.92% | 215M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HSIC Stock
- HS2 Stock
- Ratings Henry Schein, Inc.